Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Patient-Derived Cancer Organoid Cultures to Predict Sensitivity to Chemotherapy and Radiation.

Pasch CA, Favreau PF, Yueh AE, Babiarz CP, Gillette AA, Sharick JT, Karim MR, Nickel KP, DeZeeuw AK, Sprackling CM, Emmerich PB, DeStefanis RA, Pitera RT, Payne SN, Korkos DP, Clipson L, Walsh CM, Miller D, Carchman EH, Burkard ME, Lemmon KK, Matkowskyj KA, Newton MA, Ong IM, Bassetti MF, Kimple RJ, Skala MC, Deming DA.

Clin Cancer Res. 2019 Sep 1;25(17):5376-5387. doi: 10.1158/1078-0432.CCR-18-3590. Epub 2019 Jun 7.

PMID:
31175091
2.

MTORC1/2 Inhibition as a Therapeutic Strategy for PIK3CA Mutant Cancers.

Fricke SL, Payne SN, Favreau PF, Kratz JD, Pasch CA, Foley TM, Yueh AE, Van De Hey DR, Depke MG, Korkos DP, Sha GC, DeStefanis RA, Clipson L, Burkard ME, Lemmon KK, Parsons BM, Kenny PA, Matkowskyj KA, Newton MA, Skala MC, Deming DA.

Mol Cancer Ther. 2019 Feb;18(2):346-355. doi: 10.1158/1535-7163.MCT-18-0510. Epub 2018 Nov 13.

PMID:
30425131
3.

Versican-Derived Matrikines Regulate Batf3-Dendritic Cell Differentiation and Promote T Cell Infiltration in Colorectal Cancer.

Hope C, Emmerich PB, Papadas A, Pagenkopf A, Matkowskyj KA, Van De Hey DR, Payne SN, Clipson L, Callander NS, Hematti P, Miyamoto S, Johnson MG, Deming DA, Asimakopoulos F.

J Immunol. 2017 Sep 1;199(5):1933-1941. doi: 10.4049/jimmunol.1700529. Epub 2017 Jul 28.

4.

Dual PI3K/mTOR Inhibition in Colorectal Cancers with APC and PIK3CA Mutations.

Foley TM, Payne SN, Pasch CA, Yueh AE, Van De Hey DR, Korkos DP, Clipson L, Maher ME, Matkowskyj KA, Newton MA, Deming DA.

Mol Cancer Res. 2017 Feb 9;15(3):317-327. doi: 10.1158/1541-7786.MCR-16-0256. [Epub ahead of print]

5.

Colon Cancer Tumorigenesis Initiated by the H1047R Mutant PI3K.

Yueh AE, Payne SN, Leystra AA, Van De Hey DR, Foley TM, Pasch CA, Clipson L, Matkowskyj KA, Deming DA.

PLoS One. 2016 Feb 10;11(2):e0148730. doi: 10.1371/journal.pone.0148730. eCollection 2016.

6.

PIK3CA mutations can initiate pancreatic tumorigenesis and are targetable with PI3K inhibitors.

Payne SN, Maher ME, Tran NH, Van De Hey DR, Foley TM, Yueh AE, Leystra AA, Pasch CA, Jeffrey JJ, Clipson L, Matkowskyj KA, Deming DA.

Oncogenesis. 2015 Oct 5;4:e169. doi: 10.1038/oncsis.2015.28.

7.

Colon Tumors with the Simultaneous Induction of Driver Mutations in APC, KRAS, and PIK3CA Still Progress through the Adenoma-to-carcinoma Sequence.

Hadac JN, Leystra AA, Paul Olson TJ, Maher ME, Payne SN, Yueh AE, Schwartz AR, Albrecht DM, Clipson L, Pasch CA, Matkowskyj KA, Halberg RB, Deming DA.

Cancer Prev Res (Phila). 2015 Oct;8(10):952-61. doi: 10.1158/1940-6207.CAPR-15-0003. Epub 2015 Aug 14.

8.

Choriocarcinoma of the colon: report of a case and review of the literature.

Le DT, Austin RC, Payne SN, Dworkin MJ, Chappell ME.

Dis Colon Rectum. 2003 Feb;46(2):264-6. Review.

PMID:
12576901
9.

CYP3A4 promoter variant is associated with prostate cancer risk in men with benign prostate hyperplasia.

Tayeb MT, Clark C, Sharp L, Haites NE, Rooney PH, Murray GI, Payne SN, McLeod HL.

Oncol Rep. 2002 May-Jun;9(3):653-5.

PMID:
11956645
10.

Enhanced percutaneous absorption of a novel topical cyclosporin A formulation and assessment of its immunosuppressive activity.

Duncan JI, Payne SN, Winfield AJ, Ormerod AD, Thomson AW.

Br J Dermatol. 1990 Nov;123(5):631-40.

PMID:
2147390
12.

Percutaneous absorption of cyclosporin.

Thomson AW, Payne SN.

Lancet. 1988 Apr 30;1(8592):1000. No abstract available.

PMID:
2896811
14.

Changes in circulating antibody levels to the major phenolic glycolipid during erythema nodosum leprosum in leprosy patients.

Andreoli A, Brett SJ, Draper P, Payne SN, Rook GA.

Int J Lepr Other Mycobact Dis. 1985 Jun;53(2):211-7.

PMID:
3894538
15.
16.
17.
18.

Isolation of a characteristic phthiocerol dimycocerosate from Mycobacterium leprae.

Draper P, Payne SN, Dobson G, Minnikin DE.

J Gen Microbiol. 1983 Mar;129(3):859-63.

PMID:
6409988
19.

Serological activity of purified glycolipid from Mycobacterium leprae.

Payne SN, Draper P, Rees RJ.

Int J Lepr Other Mycobact Dis. 1982 Jun;50(2):220-1. No abstract available.

PMID:
6749710
20.

Ciguatera in Puerto Rico and the Virgin Islands.

Payne CA, Payne SN.

N Engl J Med. 1977 Apr 21;296(16):949-50. No abstract available.

PMID:
557726
21.

Complement and phospholipase C lysis of lipid membranes.

Hesketh TR, Payne SN, Humphrey JH.

Immunology. 1972 Nov;23(5):705-11. No abstract available.

22.

Lesions due to complement in lipid membranes.

Hesketh TR, Dourmashkin RR, Payne SN, Humphrey JH, Lachmann PJ.

Nature. 1971 Oct 29;233(5322):620-3. No abstract available.

PMID:
4939804
23.
24.

THE QUANTITATIVE SEPARATION AND ESTIMATION BY THIN-LAYER CHROMATOGRAPHY OF LIPIDS IN NERVOUS TISSUE.

PAYNE SN.

J Chromatogr. 1964 Jul;15:173-9. No abstract available.

PMID:
14203898
25.

Supplemental Content

Loading ...
Support Center